|
18 May 2020 |
OSE Immunotherapeutics Presents CLEC-1, Novel Myeloid Immune Checkpoint Target for Cancer Immunotherapy
|
|
16 May 2020 |
LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program
|
|
14 May 2020 |
Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome
|
|
14 May 2020 |
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA...
|
|
13 May 2020 |
Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
|
|
12 May 2020 |
Neurocrine Biosciences exercises option to license Idorsia's novel treatment for rare pediatric epilepsy
|
|
12 May 2020 |
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
|
|
08 May 2020 |
ACADIA Pharmaceuticals and Vanderbilt University Announce Exclusive License Agreement and Research Collaboration
|
|
07 May 2020 |
PTC Therapeutics to Acquire Censa Pharmaceuticals
|
|
07 May 2020 |
Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies
|
|
06 May 2020 |
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
|
|
06 May 2020 |
Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
|
|
06 May 2020 |
Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University
|
|
05 May 2020 |
Alexion to Acquire Portola
|
|
04 May 2020 |
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
|
|
04 May 2020 |
Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
|
|
04 May 2020 |
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
|
|
29 Apr 2020 |
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
|
|
27 Apr 2020 |
Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies
|
|
27 Apr 2020 |
Merck and Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers
|
|
24 Apr 2020 |
ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)
|
|
23 Apr 2020 |
EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations
|
|
22 Apr 2020 |
Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138
|
|
22 Apr 2020 |
Targovax and Valo Therapeutics Enter Collaboration to Develop RAS Neoantigen Coating of ONCOS Viruses Using PeptiCRAd Technology
|
|
21 Apr 2020 |
Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-Derived Regulatory T Cells
|
